RVW Wealth LLC Buys 18,585 Shares of Danaher Corporation $DHR

RVW Wealth LLC purchased a new position in shares of Danaher Corporation (NYSE:DHR) during the third quarter, HoldingsChannel reports. The fund purchased 18,585 shares of the conglomerate’s stock, valued at approximately $4,118,000.

Several other institutional investors and hedge funds also recently made changes to their positions in DHR. Colton Groome Financial Advisors LLC bought a new stake in shares of Danaher in the third quarter worth about $592,000. Ables Iannone Moore & Associates Inc. acquired a new position in shares of Danaher in the 3rd quarter valued at approximately $1,853,000. Byrne Asset Management LLC grew its position in shares of Danaher by 9,327.0% in the 3rd quarter. Byrne Asset Management LLC now owns 3,488 shares of the conglomerate’s stock valued at $773,000 after purchasing an additional 3,451 shares during the period. Central Pacific Bank Trust Division increased its stake in Danaher by 1,250.0% during the 3rd quarter. Central Pacific Bank Trust Division now owns 2,700 shares of the conglomerate’s stock worth $598,000 after purchasing an additional 2,500 shares in the last quarter. Finally, Ballew Advisors Inc acquired a new stake in Danaher during the 3rd quarter worth approximately $1,274,000. Institutional investors and hedge funds own 79.05% of the company’s stock.

Danaher Stock Down 2.6%

NYSE DHR traded down $5.72 during trading on Tuesday, hitting $215.49. The stock had a trading volume of 3,642,543 shares, compared to its average volume of 4,462,547. Danaher Corporation has a 12 month low of $160.93 and a 12 month high of $242.80. The company has a debt-to-equity ratio of 0.48, a quick ratio of 1.25 and a current ratio of 1.65. The company’s 50-day moving average price is $209.69 and its two-hundred day moving average price is $193.88. The company has a market capitalization of $151.48 billion, a PE ratio of 38.27, a P/E/G ratio of 2.67 and a beta of 0.76.

Danaher (NYSE:DHR) last issued its quarterly earnings results on Monday, July 20th. The conglomerate reported $1.94 earnings per share for the quarter, topping the consensus estimate of $1.85 by $0.09. Danaher had a net margin of 15.95% and a return on equity of 11.04%. The company had revenue of $6.26 billion during the quarter, compared to analysts’ expectations of $6.12 billion. During the same period last year, the business earned $0.77 EPS. The business’s quarterly revenue was up 5.5% on a year-over-year basis. As a group, sell-side analysts forecast that Danaher Corporation will post 8.53 EPS for the current year.

Danaher Dividend Announcement

The firm also recently announced a quarterly dividend, which will be paid on Friday, October 30th. Investors of record on Wednesday, September 30th will be given a $0.40 dividend. The ex-dividend date of this dividend is Wednesday, September 30th. This represents a $1.60 dividend on an annualized basis and a yield of 0.7%. Danaher’s dividend payout ratio (DPR) is 28.42%.

Analyst Ratings Changes

A number of research analysts have weighed in on the stock. Stifel Nicolaus cut their price target on shares of Danaher from $260.00 to $220.00 and set a “buy” rating on the stock in a research note on Wednesday, July 22nd. TD Cowen lowered their price objective on shares of Danaher from $240.00 to $236.00 and set a “buy” rating for the company in a research report on Wednesday, July 22nd. Deutsche Bank Aktiengesellschaft restated a “buy” rating and set a $240.00 price objective on shares of Danaher in a report on Wednesday, July 22nd. Piper Sandler initiated coverage on shares of Danaher in a research note on Thursday, June 11th. They issued a “neutral” rating and a $200.00 target price for the company. Finally, Guggenheim upped their target price on shares of Danaher from $200.00 to $250.00 and gave the stock a “buy” rating in a research note on Thursday, October 1st. Two equities research analysts have rated the stock with a Strong Buy rating, seventeen have assigned a Buy rating and five have assigned a Hold rating to the stock. According to MarketBeat.com, the stock has a consensus rating of “Moderate Buy” and a consensus target price of $234.09.

Danaher Company Profile

Danaher Corporation (NYSE: DHR) is a global science and technology company that develops and manufactures products, services and solutions for the life sciences, diagnostics and biotechnology industries. Its offerings help researchers, healthcare professionals and biopharmaceutical manufacturers discover, develop, produce and analyze medicines and other biological products.

The company operates through businesses that provide laboratory instruments, consumables, software and services, including technologies for cell analysis, genomics, protein research, bioprocessing and clinical diagnostics.